R Bissonnette Selected Research

R Bissonnette Research Topics

Disease

27	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 01/2001
9	Atopic Dermatitis (Atopic Eczema) 06/2023 - 04/2012
5	Eczema 02/2022 - 04/2008
4	Actinic Keratosis 06/2012 - 06/2001
3	Pruritus (Itching) 10/2019 - 03/2011
3	Acne Vulgaris 04/2017 - 03/2009
2	Headache (Headaches) 01/2020 - 04/2008
2	Psoriatic Arthritis 09/2018 - 02/2006
2	Necrosis 08/2015 - 06/2015
2	Basal Cell Carcinoma (Rodent Ulcer) 05/2014 - 04/2006
2	Skin Neoplasms (Skin Cancer) 06/2012 - 07/2008
2	Pain (Aches) 12/2011 - 03/2011
1	Dermatitis 06/2023
1	Sleep Deprivation 05/2023
1	Tuberculosis (Tuberculoses) 02/2021
1	Neoplasms (Cancer) 02/2021
1	Venous Thromboembolism 01/2020
1	Nasopharyngitis 01/2020
1	Inflammation (Inflammations) 10/2019
1	Atherosclerosis 10/2019
1	Hyperhidrosis 01/2018
1	Cicatrix (Scar) 04/2017
1	Skin Diseases (Skin Disease) 10/2014
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 05/2014
1	Drug-Related Side Effects and Adverse Reactions 12/2012
1	Melanoma (Melanoma, Malignant) 06/2012
1	Sunburn 07/2008
1	Rheumatoid Arthritis 02/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001
1	Mycosis Fungoides 01/2001
1	Erythema 11/2000
1	Alopecia Areata 11/2000

Drug/Important Bio-Agent (IBA)

8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2014 - 11/2000
6	Etanercept (Enbrel)FDA Link 08/2015 - 02/2006
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2002
5	Prostaglandins AIBA 10/2018 - 03/2011
5	AcidsIBA 12/2011 - 11/2000
4	tofacitinibIBA 10/2018 - 01/2013
3	tapinarofIBA 06/2023 - 04/2012
3	secukinumabIBA 09/2018 - 09/2015
3	Monoclonal AntibodiesIBA 09/2018 - 11/2001
3	Janus Kinase InhibitorsIBA 01/2018 - 01/2013
3	Alitretinoin FDA Link 03/2011 - 04/2008
2	baricitinibIBA 02/2021 - 01/2020
2	Janus KinasesIBA 02/2021 - 10/2019
2	Interleukin-23 (Interleukin 23)IBA 01/2019 - 10/2014
2	Interleukin-17 (Interleukin 17)IBA 09/2018 - 10/2014
2	Benzoyl Peroxide FDA LinkGeneric 04/2017 - 03/2009
2	Adalimumab (Humira)FDA Link 08/2015 - 06/2015
2	Infliximab (Remicade)FDA Link 08/2015 - 12/2011
2	Ustekinumab (CNTO 1275)FDA Link 06/2015 - 12/2013
2	Ointments (Pastes)IBA 01/2013 - 01/2002
2	Photosensitizing Agents (Photosensitizers)IBA 12/2011 - 04/2006
2	protoporphyrin IXIBA 04/2006 - 08/2001
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2023
1	Immunoglobulin A (IgA)IBA 02/2022
1	tildrakizumabIBA 01/2020
1	Janus Kinase 1IBA 01/2020
1	Syk KinaseIBA 10/2019
1	gusacitinibIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	E-SelectinIBA 10/2019
1	mirikizumabIBA 01/2019
1	InterleukinsIBA 01/2019
1	ixekizumabIBA 10/2018
1	apremilastIBA 03/2018
1	GSK573719IBA 01/2018
1	Adapalene (Differin)FDA LinkGeneric 04/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015
1	Interleukin-12 (IL 12)IBA 06/2015
1	pneumococcal purpura-producing principle (PPPP)IBA 10/2014
1	PorphyrinsIBA 12/2011
1	Hydroxy AcidsIBA 03/2009
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 03/2009
1	Sunscreening Agents (Sunscreens)IBA 07/2008
1	Calcineurin InhibitorsIBA 04/2008
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2008
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2008
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2002
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 01/2002
1	calcipotriol drug combination betamethasone dipropionate FDA Link 01/2002
1	Aminolevulinic Acid (Levulan)FDA Link 08/2001
1	Triglycerides (Triacylglycerol)IBA 04/2001
1	fibric acidIBA 04/2001

Therapy/Procedure

13	Therapeutics 05/2023 - 04/2008
8	Photochemotherapy (Photodynamic Therapy) 05/2014 - 11/2000
2	Retreatment 01/2015 - 02/2010
1	Phototherapy (Light Therapy) 07/2016
1	Oral Administration 08/2001